Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

T2 Biosystems Shares Nearly Double on Worldwide COVID-19 Testing License Deal

Shares of T2 Biosystems Inc. traded 90% higher after the company reported that a new COVID-19 assay licensed from Hackensack Meridian Health's Center for Discovery and Innovation will be adapted to run on its FDA-cleared T2Dx® Instrument. Diagnostic...

As Drone Market Changes, This Small Cap Offers Opportunities

In my first write up about drones, I used the phrase "The Drones are coming." Perhaps now it is more appropriate "The Drones are multiplying like rabbits." The FAA announced that there were more than 122,000 commercial drone pilots in early 2018. Combined with the 87...

PlantX Life: Must-see Investor Update with CEO Julia Frank

(Click image to play video) They truly have become “the digital face of the plant-based community” and they’re called Plant-X Life Inc. (VEGA) ( CSE.VEGA , Forum ) – a one-stop-shop and distribution company with a fast-gr...

BVT's Chairman On Agritech Firm's Massive Growth and Success

Investors are getting excited over a radical new farming technology that is making waves in the media, and in the market. Omri Wallach of Stockhouse Media was recently joined by Michael Collinson, Chairman of the company behind the technology, Bee Vectoring...

Biotech Firm ''Creating Innovative Solutions' for Female Health

The company's most advanced assets are discussed in a Dawson James Securities report. In a July 18 research note, Dawson James Securities analyst Jason Kolbert reported he assumed coverage on Daré Bioscience Inc. (DARE:NASDAQ) , and in doing so, rated it Bu...

Regenerative Medicine Firm Reports Early Results from COVID-19 Trials

Pluristem Therapeutics' coronavirus clinical studies and financing are discussed in a Dawson James report. In a June 11 research note, Dawson James analyst Jason Kolbert reported that Pluristem Therapeutics Inc. (PSTI:NASDAQ) announced the status of COVID-19-infe...

How Much Crude Oil Do You Unknowingly Eat?

You may think (or hope) that in your daily life you don't need to worry about unknowingly eating or otherwise ingesting crude oil or any of its many, many petrochemical byproducts. But you would be wrong. And not just a little wrong--very, very wrong. Petroleum-based substance...

Novamind Selected by Merck to Advance Research for Treatment-Resistant Depression

Novamind’s subsidiary, Cedar Clinical Research, to serve as a key clinical research site Independent validation of the expertise and capabilities of Novamind in managing clinical trials Adds to established track record conducting research a...

Science FACT: The Future of Food is Here…Today

Welcome to the future of food science…happening right now. CULT Food Science Corp. ( CSE.CULT , OTCQB:CULTF , Forum ) is an innovative platform advancing the future of food with an exclusive focus on cultivated meat, cultured dairy, and cell-based foods. The first...

Analyst Upgrade Ignites Duchenne's Muscular Dystrophy Research Firm's Shares

Solid Biosciences' shares are up by more than 40% today after Chardan Capital Markets upgraded the firm's shares from "neutral" to "buy" and raised its price target from $7.50 to $10.00/share. Duchenne muscular dystrophy (DMD) research firm Solid Biosciences ...
1 2 3 4 5 6 7 8 9 10 ...